148927-81-5Relevant articles and documents
1-(((7,7-Dimethyl-2(S)-(2(S)-amino-4- (methylsulfonyl)butyramido)bicyclo[2.2.1]-heptan-1(S)-yl)methyl)sulfonyl)-4- (2-methylphenyl)piperazine (L-368,899): An orally bioavailable, non-peptide oxytocin antagonist with potential utility for managing preterm
Williams,Anderson,Ball,Bock,Carroll,Chiu -,Clineschmidt,Culberson,Erb,Evans,Fitzpatrick,Freidinger,Kaufman,Lundell,Murphy,Pawluczyk,Perlow,Pettibone,Pitzenberger,et al.
, p. 565 - 571 (2007/10/02)
Modifications to the previously reported spiroindenylpiperidine camphorsulfonamide oxytocin (OT) antagonist L-366,509 have produced a new series of o-tolylpiperazine (TP) camphorsulfonamides. A number of analogues in the TP series that incorporate a modif